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Abstract
Excess maternal fat intake and obesity increase offspring susceptibility to conditions such as chronic anxiety and substance 
abuse. We hypothesised that environmentally modulated DNA methylation changes (5mC/5hmC) in regulatory regions of 
the genome that modulate mood and consumptive behaviours could contribute to susceptibility to these conditions. We 
explored the effects of environmental factors on 5mC/5hmC levels within the GAL5.1 enhancer that controls anxiety-related 
behaviours and alcohol intake. We first observed that 5mC/5hmC levels within the GAL5.1 enhancer differed significantly 
in different parts of the brain. Moreover, we noted that early life stress had no significant effect of 5mC/5hmC levels within 
GAL5.1. In contrast, we identified that allowing access of pregnant mothers to high-fat diet (> 60% calories from fat) had 
a significant effect on 5mC/5hmC levels within GAL5.1 in hypothalamus and amygdala of resulting male offspring. Cell 
transfection-based studies using GAL5.1 reporter plasmids showed that 5mC has a significant repressive effect on GAL5.1 
activity and its response to known stimuli, such as EGR1 transcription factor expression and PKC agonism. Intriguingly, 
CRISPR-driven disruption of GAL5.1 from the mouse genome, although having negligible effects on metabolism or general 
appetite, significantly decreased intake of high-fat diet suggesting that GAL5.1, in addition to being epigenetically modulated 
by high-fat diet, also actively contributes to the consumption of high-fat diet suggesting its involvement in an environmentally 
influenced regulatory loop. Furthermore, considering that GAL5.1 also controls alcohol preference and anxiety these studies 
may provide a first glimpse into an epigenetically controlled mechanism that links maternal high-fat diet with transgenera-
tional susceptibility to alcohol abuse and anxiety.
Keywords GAL5.1 enhancer sequence · CRISPR genome editing · Galanin · EGR1 · Protein Kinase C · Gene regulation · 
5mC/5hmC content · Early life stress · Fat preference · Anxiety and substance abuse
Background
In addition to their acute involvement in obesity [1, 2] 
there is evidence that diets high in fat are associated with 
an increase in anxiety and substance abuse in subsequent 
human generations [3, 4]. Consistent with these observa-
tions in humans, high-fat diet and maternal obesity is also 
associated with an increase in anxiety-like behaviour in 
mouse models. For example, decreased entries into the open 
arms of the elevated plus maze was observed in offspring 
of C57BL/6 mothers fed high-fat diet [5–7] and in Oldfield 
mice [8]. Later studies demonstrated that, in addition to 
increased anxiety-like behaviours, increased maternal HFD 
also altered the expression of a number of epigenetic regula-
tory molecules such as DNA methyltransferase 3a and b [9]. 
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These studies raise the possibility that the effects of high-
fat diet on the anxiety phenotype of subsequent offspring 
may have an epigenetic contribution. In addition, studies in 
rats suggest that maternal HFD can also influence intake of 
alcohol and nicotine in offspring [10]. Therefore, in addition 
to gaining an understanding of the molecular mechanisms 
regulating fat intake, anxiety and substance abuse there is 
also a priority to uncover the genomic and epigenetic mecha-
nisms that contribute in linking high-fat diet to anxiety and 
substance abuse disorders.
Nutrient intake (fats and ethanol) and mood are controlled 
by the expression of neuropeptides in regions of the brain 
that include the hypothalamus and amygdala respectively 
[11]. The expression of one of these neuropeptides; galanin, 
a 30 amino acid peptide encoded by the GAL gene, contrib-
utes to the regulation of fat intake in animals [2, 12–14], 
plays a role in modulating mood [15–18] and regulates 
ethanol intake [19–22]. Considering its important role in 
these processes, much remains to be determined regarding 
the mechanisms that regulate the tissue-specific expres-
sion of the GAL gene. In order to address this knowledge 
gap we previously used comparative genomics to identify 
a highly conserved enhancer sequence (GAL5.1) that lay 
42 kilobases (kb) 5′ of the GAL gene transcriptional start 
site in humans. We then demonstrated its activity in galanin 
expressing cells of the hypothalamus including the periven-
tricular nucleus (PVN), dorsomedial hypothalamus (DMH) 
and arcuate nucleus (ARC) [23, 24]. The analysis of two 
polymorphisms in the human GAL5.1 enhancer using the 
UK Biobank cohort suggested a mechanistic link between 
allelic variants of these polymorphisms and alcohol abuse 
when stratified against sex (male) and anxiety [24]. Subse-
quent use of CRISPR genome editing, to disrupt the mouse 
GAL5.1 enhancer (mGAL5.1KO), demonstrated a role for 
mGAL5.1 in the tissue specific expression of the Gal gene 
in hypothalamus and amygdala as well as the modulation of 
alcohol intake and male anxiety-like behaviour [24].
Because increased susceptibility to anxiety and alcohol 
abuse occured in offspring of mothers fed a high-fat diet dur-
ing pregnancy, we used the well characterised maternal high-
fat diet [5–7] and maternal separation stress [25] paradigms 
in mice to explore the hypothesis that the anxiety and alco-
hol intake modulating GAL5.1 enhancer could be epigeneti-
cally influenced by environmental stimuli that include early 
life stress and high-fat diet. We also explored the effects 
of DNA methylation on GAL5.1 activity and its interac-
tions with, and response to, known stimulators of GAL5.1 
activity such as PKC agonism and EGR1 transcription factor 
expression. Finally, we asked whether deleting the GAL5.1 
enhancer from the mouse genome using CRISPR genome 
editing has any effect on appetite, metabolism or selection of 
high-fat diet. We discuss our findings in the wider context of 
a role for GAL5.1 genetics and epigenetics in modulating fat 
intake as well as the possible role of altered GAL5.1 activity 




All animal studies were performed in full accordance with 
UK Home Office guidelines. Animals were maintained 
under specific pathogen-free (SPF) facilities. The health sta-
tus of these animals conformed to The Federation of Euro-
pean Laboratory Animal Science Associations (FELASA) 
guidelines whereby pathogen screening was carried out on 
a quarterly (3 monthly) basis using sentinel animals. Male 
and female homozygous wildtype and mGAL5.1KO age 
matched littermates were single housed under standard 
laboratory conditions (12 h light/12 h dark cycle), in plastic 
cages with food and water available ad libitum, depending 
on the experiment.
Epigenetic effects of early life stress by maternal 
deprivation
Wildtype C57BL/6 females were housed with wildtype 
C57BL/6 males and allowed ad-libitum access to standard 
CHOW diet. Once females became pregnant males were 
removed and females were allowed to litter down. Immedi-
ately after birth mothers were removed from the cages for 
two hours a day for the first 12 days as previously described 
[25]. Once weaned, litters were humanely sacrificed by 
euthatol injection and brain tissues (hypothalamus, hip-
pocampus and amygdala) recovered and rapidly frozen on 
dry ice.
High‑fat diet studies
Wildtype C57BL/6 wildtype animals were housed with 
wildtype C57BL/6 males and allowed ad libitum access to a 
choice of low-fat diet (LFD; 22.03 kcal% protein, 68.9 kcal% 
carbohydrate and 9.08 kcal% fat) or high-fat diet (HFD; 
20 kcal% protein, 20 kcal% carbohydrate and 60 kcal % fat; 
Research Diets Inc.) in different hoppers. Both hoppers were 
weighed regularly to ensure intake of HFD and LFD. Once 
females became pregnant males were removed and females 
allowed to litter down. After weaning (3-4 weeks), animals 
were humanely sacrificed by euthasol injection and brain tis-
sues (hypothalamus, hippocampus and amygdala) recovered 
and rapidly frozen on dry ice.
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DNA extraction bisulphite conversion 
and pyrosequencing
Genomic DNA was extracted and purified with the All-
Prep DNA/RNA Mini Kit (Qiagen) and optimized for 
10–15 mg brain tissue as per manufacturer’s instructions. 
The concentration and purity of genomic DNA was deter-
mined using a Nanodrop  OneC (Thermo) and 500 ng of 
genomic DNA was bisulphite-converted using the Epi-
Mark Bisulfite Conversion Kit (New England BioLabs) 
as per manufacturer’s instructions. The mouse GAL5.1 
enhancer region analysed (chr19:3,441,054–3,441,445, 
GRCm38/mm10) contained 8 CpG sites (see Fig. 1). Prim-
ers were used to amplify two regions of the mouse Gal5.1 
enhancer covering 8 CpGs: CpGs 4–8 (F–TTT AGT AGA 
GGA AAT AAA ATA GTA GAA AAA -Biotinylated; R: CCC 
CAA AAA ACC ACA AAA CCTA) CpGs 9–11 (F – GGA 
TGG AGG AAT TTT TTT GTGTT; R: CCC CAA AAA ACC 
ACA AAA CCTA -Biotinylated) using MyTaq HS mix PCR 
reagents (Bioline). Amplicons were processed on the Qia-
gen Q24 Workstation and sequenced in duplicate on the 
Qiagen Q24 pyrosequencer using the sequencing prim-
ers CpGs 4–8 (AAC AAT TTA AAC AAA AAA TAA CAT T) 
CpGs 9–11 (GAG TTT GAT TGA TAA TAG TAG TAT ) and 
DNA methylation levels across each CpG measured. These 
were expressed as percentage methylation.
Reporter assays
The human GAL5.1 enhancer was cloned into the pCpGfree-
promoter-lucia vector (InvivoGen; contains the EF1α pro-
moter) and subjected to CpG methylation using SssI (New 
England Biolabs) as described in manufacturer’s instruc-
tions. Methylated and unmethylated plasmids were trans-
fected into SHSY-5Y cells vector using Jetprime transfec-
tion reagent (Polyplus-transfection) and incubated for 24 h. 
Cells were lysed using passive lysis buffer and the activity 
of the enhancer assessed using a Lucia QUANTI-Luc Gold 
Assay #3 luciferase kit (InvivoGen). Lucia activity levels 
were normalised against quantitative PCR (qPCR) of levels 
of Lucia gene DNA present in cell extracts recovered using 
Qiagen PCR cleanup kits (Qiagen). Lucia luciferase activity 
was normalised against the crossing point (Cp) values gen-
erated from quantitative polymerase chain reaction (qPCR) 
of the lucia reporter vector. Absolute quantification of the 
transfected lucia reporter vector was determined in order 
to verify transfection efficiency between all samples. After 
media from cell wells was extracted, the cells were lysed 
using 100 µl passive lysis buffer (Promega) per well. Total 
DNA was isolated from the cell lysates using the  QIAquick® 
PCR Purification Kit (QIAGEN). The following primers 
used were designed to the lucia DNA sequence for amplifi-
cation of the reporter gene (JE041; 5′- GAA ATC AAG GTG 
CTG TTT GC-3′, JE042; 5′- TAT CAT CTG TCC CCA GCC 
-3′). Samples were loaded into an opaque 384-well plate 
Fig. 1  Levels of DNA meth-
ylation (5mC/5hmC) within 
GAL5.1 differs significantly 
between specific tissues and is 
affected by maternal access to 
high-fat diet, but not early life 
stress. a Bar plot demonstrating 
differential levels of 5mC/5hmC 
that occur within the GAL5.1 
enhancer in DNA derived from 
hypothalamus (hypo), amyg-
dala (amgd) and hippocampus 
(hipp) (n > 10). B–D Scat-
terplots showing the effects of 
high-fat diet (HFD) and early 
life stress (ELS) on 5mC levels 
of GAL5.1 derived from hip-
pocampus (b), hypothalamus 
(c) and amygdala (d). n.s.; not 
significant, *; p < 0.05, **; 
p < 0.01, ***; p < 0.005
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in triplicate following the standard cycling parameters of a 
SYBR Green protocol with 60 °C annealing temperature. 
Amplification and quantitative analysis were carried out 
using the  LightCycler® 480 System (Roche).
High‑fat preference studies
Mice containing a disrupted GAL5.1 enhancer [24] were 
maintained as a colony on a heterozygous C57BL/6 back-
ground which was mated to produce homozygous wildtype 
and homozygous GAL5.1 KO age matched and sex matched 
individuals. These were identified using PCR of earclip 
DNA [24]. Once identified, animals were assigned ran-
dom numbers to hide their genotype from the operators of 
subsequent tests. For high-fat diet preference studies, sin-
gly housed animals were provided with a choice of LFD 
or HFD in different hoppers. The position of each hopper 
was changed regularly to rule out the possibility of position 
effects. Animals were weighed daily over a period of 23 days 
and LFD and HFD were also weighed daily to determine 
intake of each diet.
Metabolic analysis
Wildtype and GAL5.1KO animals were maintained for one 
week in sealed TSE metabolic cages where calorie intake 
(kcal/hour),  O2 consumption (ml/hr), energy expenditure 
(kcal/hour) locomotor activity,  CO2 production (ml/hour), 
energy balance (kcal/hr) respiratory exchange ratios and 
locomoter activity (beam breaks) were continuously moni-
tored for 144 h with readings taken at 30 min intervals.
Data analysis
From in-vivo pilot studies we calculated that a minimum 
of 6–8 animals per group would enable detection of a 25% 
difference between different parameters (e.g., high-fat diet, 
weight gain, metabolism) with 80% power using one-way 
ANOVA and/or general linear modelling. Statistical signifi-
cance of data sets were analysed using either two way analy-
sis of variance (ANOVA) analysis with Bonferroni post hoc 
tests or using one tailed or two tailed unpaired parametric 
Student t test as indicated using GraphPad PRISM version 
5.02 (GraphPad Software, La Jolla, CA, USA).
Results
We have previously shown that the GAL5.1 enhancer con-
trols anxiety and alcohol intake [24]. This provided us with 
a unique opportunity to determine the effects of environ-
mental factors such as dietary changes and early life stress 
on 5mC/5hmC levels within an enhancer region shown to 
control behaviours with a direct effect on human health. We 
first needed to establish normal levels of DNA methylation 
(5mC/5hmC) within GAL5.1 in different brain regions and 
to determine whether these levels differed between different 
brain regions.
Levels of 5mC/5hmC within GAL5.1 varies 
significantly between brain regions
We first asked whether levels of 5mC/5hmC within GAL5.1 
differed between different brain regions. To address this 
question, DNA from 3 different brain tissues (hypothalamus, 
amygdala and hippocampus) was recovered from mouse 
pups and bisulfite converted to detect levels 5mC/5hmC 
within GAL5.1 analysed using pyrosequencing (n > 10). 
We observed that 5mC/5hmC levels within GAL5.1 varied 
considerably between different brain tissues such that in hip-
pocampus 5mC levels only reached 23–32% within GAL5.1. 
However, in amygdala and hypothalamus 5mC/5hmC levels 
were between 35 and 50% (Fig. 1a).
5mC/5hmC levels within GAL5.1 is not affected 
by early life stress
We next asked whether early life stress; an environmental 
factor known to affected enhancer 5mC/5hmC levels [25, 
27] affected the methylation of the GAL5.1 enhancer in 
hypothalamus, hippocampus or amygdala. To address this 
question, we subjected newborn wildtype C57BL/6 mouse 
pups to maternal separation stress for 2 h a day for the first 
12 days of their lives as previously described [25]. After 
weaning of these mice, DNA from 3 different brain tissues 
(hypothalamus, amygdala and hippocampus) was recov-
ered, bisulphite converted and levels of 5mC/5hmC within 
GAL5.1 analysed using pyrosequencing. We did not observe 
any significant changes in 5mC/5hmC levels in any of the 
tissues recovered from animals subjected to early life stress 
(Fig. 1b-d).
GAL5.1 displays significantly altered 5mC/5hmC 
levels in animals whose mothers had access to HFD
In order to address the possible role of high-fat diet in alter-
ing 5mC/5hmC levels within GAL5.1 we provided preg-
nant mice with a choice of low-fat or high-fat diet during 
pregnancy and during the rearing of their pups. Following 
weaning, pups were humanely sacrificed and genomic DNA 
was recovered from tissues dissected from hypothalamus, 
hippocampus and amygdala. This DNA was subjected to 
bisulphite conversion and pyrosequenced to determine 
changes in 5mC/5hmC levels within the GAL5.1 enhancer 
in the presence of access to HFD. We were unable to detect 
any changes in GAL5.1 5mC levels in DNA derived from 
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hippocampal tissues of animals whose mothers had access 
to high-fat diet (Fig. 1b). However, significant changes in 
CpG methylation were observed in DNA derived from the 
hypothalamic regions of animals whose mothers had been 
exposed to high-fat diet such that there was a significant 
increase in methylation in males and a clear divergence 
in methylation between males and females (Fig. 1c). This 
increase in male GAL5.1 5mC levels and sexual divergence 
was more pronounced in DNA derived from amygdala 
(Fig. 1d).
Increasing 5mC levels within the GAL5.1 enhancer 
suppresses its activity and its response to EGR1 
binding and PKC activation
In addition to examining the effects of environmental factors 
on levels of 5mC/5hmC within GAL5.1 we also explored the 
effects of DNA methylation on the activity of GAL5.1 as 
well as its response to known stimuli such as PKC stimula-
tion and expression of EGR1 [23, 24]. To address this ques-
tion, we first cloned the human GAL5.1 (GG) enhancer into 
the pCpGfree-promoter-Lucia luciferase vector that lacks 
CpG dinucleotides and contains the EF-1α promoter. We 
then subjected this vector to CpG methylation using the 
bacterial SssI enzyme. Levels of plasmid methylation were 
monitored using digestion by the HpaII enzyme which is 
sensitive to methylated CpG sites (Figure S1). Methylated or 
unmethylated plasmid were then transfected into SHSY-5Y 
neuroblastoma cells in the presence of an expression vec-
tor expressing the EGR1 transcription factor (Fig. 2). These 
cells were then cultured for 24 h in the absence or pres-
ence of the PKC agonist PMA. Due to evidence of trans-
interactions between our renilla control and the pCpG-lucia 
vector (probably through the EF-1α promoter), we devised 
an alternative transfection control based on quantitative PCR 
of the Lucia reporter gene. We observed that the GAL5.1 
enhancer increased expression of Lucia luciferase compared 
with the empty vector but that this increase was negated by 
CpG methylation (Fig. 2). The previously reported stimula-
tory effects of either EGR1 co-expression or activation of the 
PKC pathway [23, 24] were similarly reduced by GAL5.1 
methylation (Fig. 2). Interestingly, we observed that the 
activity of the non-methylated GAL5.1 enhancer was not 
significantly different from that of the methylated enhancer 
co-stimulated by both EGR1 expression and PKC activation 
(Fig. 2) suggesting that, together, EGR1 expression and PKC 
stimulation can overcome much of the effects of 5mC on 
GAL5.1 activity.
mGAL5.1KO mice do not demonstrate significant 
changes in weight gain or intake of CHOW diet
We have shown that maternal high-fat diet induces changes 
in levels of 5mC/5hmC within the GAL5.1 enhancer that we 
know controls anxiety like behaviour and ethanol intake in 
mice. We also know that deleting GAL5.1 greatly reduces 
Fig. 2  DNA methylation with SssI modulates the effects of PKC ago-
nism and EGR1 transcription factor expression on the activity of the 
GAL5.1 enhancer. A bar graph demonstrating relative Lucia Lucif-
erase activity of the pCpG-free vector (white bars), the pCpGfree-
GAL5.1 (Grey bars) and pCpGfree-GAL5.1 methylated using SssI 
(Black bars) and co-transfected with the pcDNA-EGR1 expression 
vector (EGR1; bars 3–5 and 10–12) or treated with the PKC agonist 
PMA (PMA; bars 7–12). Each Lucia luciferase values was normal-
ised against the relative quantities of Lucia luciferase DNA detected 
in each cell extract using quantitative PCR. n = 4, n.s.; not significant, 
**; p < 0.01, ***; p < 0.005
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the expression of the GAL gene [23, 24] in hypothalamus 
whose expression in this brain region controls fat intake 
[2, 12–14]. However, in order to explore the possibility 
that disrupting GAL5.1 had an effect on general appetite 
we first monitored food intake and weight gain of male 
and female homozygous wildtype (WT) and mGAL5.1KO 
animals provided with a standard CHOW diet. We found 
that, after 18–24 weeks, neither male nor female animals 
demonstrated significant differences in weight gain when 
compared with wildtype animals (Fig. 3a). We also found 
that GAL5.1KO animals ate similar levels of CHOW diet to 
WT animals (Fig. 3b) demonstrating that GAL5.1 did not 
control general appetite.
mGAL5.1KO mice do not demonstrate significant 
metabolic differences to WT animals
In order to explore the possibility that disruption of GAL5.1 
significantly altered metabolism we subjected mGAL5.1KO 
and wildtype male and female littermates to 116 h of meta-
bolic analysis using sealed TSE cages that monitored vari-
ables such as O2 consumption, CO2 production (ml/hour), 
energy expenditure ration (kcal/hour) and energy balance 
(Kcal/hour). Over the 116 h of the analysis we detected lit-
tle or no significant difference in  O2 consumption (Fig. 4a), 
 CO2 production (Fig. 4b) or energy expenditure (Fig. 4c) in 
male and female mice. however, we detected a significant 
decrease in the respiratory exchange ratio (Fig. 4d) in male 
animals that suggested higher activity levels. We observed 
an increase in distance travelled by male mGAL5.1KO ani-
mals (Fig. 4e) in addition to an increase in overall speed 
(Fig. 4f) consistent with higher levels of exploratory behav-
iour associated with the reduced anxiety phenotype previ-
ously reported [24].
mGAL5.1KO mice exhibit decreased preference 
for high‑fat diet
We demonstrate above that deleting the GAL5.1 enhancer 
had no significant effect on the intake of standard CHOW 
diet or the metabolism of animals fed this diet. However, pre-
vious studies demonstrated that deletion of exons 2–6 of the 
Gal gene in mice using ES-cell targeting [28] caused a sig-
nificant reduction in the intake of high-fat diet by these ani-
mals compared with wildtype littermates but had no signifi-
cant effects on protein or carbohydrate intake [14]. Because 
we have previously shown that disruption of the GAL5.1 
enhancer resulted in a significant decrease of Gal mRNA 
expression in hypothalamus [24] we tested the hypothesis 
that CRISPR disruption of mGAL5.1 would affect prefer-
ence for HFD in these mice. We provided singly housed, 
age- and sex-matched, littermate wildtype and mGAL5.1KO 
animals with a choice of low-fat diet (LFD; 6% of calo-
ries from fat) or high-fat diet (HFD; 60% of calories from 
fat) and monitored intake of LFD and HFD over 23 days. 
Both male and female mGAL5.1KO mice consumed signifi-
cantly less HFD overall compared with wildtype littermates 
(Fig. 5a). Analysis of the total intake of LFD demonstrated 
no significant differences between the intake of wildtype and 
mGAL5.1KO animals (Fig. 5b). These experiments support 
the hypothesis that GAL5.1 is involved in driving a prefer-
ence for high-fat food but not overall food intake.
Discussion
Studies have suggested that increased maternal high-fat 
intake and obesity in both humans [3, 4] and animal mod-
els [5, 10] increase susceptibility to substance abuse and 
increased anxiety in resulting offspring. In the current study 
we explored the hypothesis that a contributing mechanism 
linking maternal high-fat diet and anxiety/substance abuse 
in offspring could involve the epigenetic modification of 
tissue specific enhancer regions through DNA methylation 
Fig. 3  mGAL5.1KO animals 
do not differ significantly 
from wildtype animals in food 
intake or weight gain. a Scat-
terplots showing a comparison 
of weights of male (m) and 
female (f) mGAL5.1KO (KO) 
and wildtype (WT) animals at 
24 weeks of age. b A com-
parison of daily CHOW intake 
of male and female wildtype 
and knock out animals. ns not 
significant
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Fig. 4  mGAL5.1KO mice do 
not differ significantly in their 
metabolism. a–d; Scatter-
plots showing a comparison 
of average  O2 consumption 
(a),  CO2 output (b), energy 
expenditure (c) and respiratory 
exchange ratio (d) in male (m) 
and female (f) mGAL5.1KO 
(KO) and wildtype (WT) 
animals recorded using sealed 
TSE cages. E, average speed 
(cm/second) and (f) distance 
travelled per hour (cm/hour). 
*; p < 0.05, n.s. not significant 
(ANOVA), Φ = significant 
(2-tailed t test)
Fig. 5  GAL5.1KO mice con-
sume significantly less high-fat 
diet. a and b; scatterplots com-
paring daily intake in grams (g) 
of (a) high-fat diet and (b) low-
fat diet comparing male (m) and 
female (f) GAL5.1KO (KO) and 
wildtype (WT) mice. ns = not 
significant, ****; p < 0.001
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[29–31]. Our decision to explore a role for 5mC/5hmC in 
this process was based on the previous studies which showed 
that environmental challenges, such as high-fat diet and early 
life stress, change levels and distributions of 5mC/5hmC 
in the genomes of experimental animals [25, 32] and alter 
enhancer activity through interaction with DNA-binding 
proteins [33].
Because of its demonstrated role in controlling anxiety-
like behaviour and ethanol intake, we focussed our attention 
on the CpG methylation of an enhancer sequence; called 
GAL5.1, which we have previously shown is responsible 
for supporting expression of the Gal gene in the hypothala-
mus and amygdala [23, 24]. We first asked whether envi-
ronmental factors associated with poverty and deprivation 
in Western countries; including early life stress by maternal 
deprivation or consumption of high-fat diet, altered levels 
of DNA methylation within 8 CpG dinucleotides contained 
within the GAL5.1 enhancer sequence. We first noted sig-
nificant differences in 5mC/5hmC levels in GAL5.1 derived 
from different tissues such that GAL5.1 from hippocampal 
tissues had the lowest 5mC/5hmC levels and hypothalamus 
and amygdala demonstrated the highest levels. These are 
interesting observations as the vast majority of large human 
cohort epigenome studies have based their analysis of lev-
els and distribution of 5mC/5hmC on DNA derived from 
peripheral blood. However, given the observed differences 
in 5mC/5hmC levels observed between different brain tis-
sues in the current study we suggest that caution should be 
exercised when interpreting studies based on the extrapola-
tion of 5mC/5hmC levels in DNA derived peripheral blood 
to specific regions of the brain.
Although the repressive effects of 5mC on promoter 
activity through mechanisms involving the recruitment of 
methyl-CpG-binding proteins (MBD) and histone deacety-
lase (HDAC) containing complexes are well established and 
accepted [34, 35] the same cannot be said for remote tis-
sue specific enhancer regions. For example, using DNAse 
hypersensitivity; a widely accepted marker of active enhanc-
ers, the ENCODE consortium only observed a decrease in 
chromatin accessibility in 20% of accessible sites as a result 
of CpG methylation suggesting that the remaining 80% of 
DNAseI hypersensitivity sites (markers of active enhancers) 
were still active despite increased 5mC levels [36]. Further-
more, an analysis of the effects of 5mC on the ability of 
542 transcription factors (TFs) to bind DNA; an essential 
component of enhancer activation; found that only 23% of 
TFs experienced reduced binding as a result whereas the 
binding of 34% of TFs was actually increased by 5mC and 
the remaining TFs were unaffected [37]. The role of DNA 
methylation in influencing enhancer activity is further com-
plicated by the influence of intermediate oxidation products 
of 5mC; that include 5-hydroxymethyl-cytosine (5hmC), the 
product of the ten-eleven translocation (TET) dioxygenase 
enzymes [38]. 5hmC sites are attractive to transcription fac-
tors that activate transcription [39]. 5hmC has been associ-
ated with active enhancers in stem cells [40, 41] and deletion 
of TET2 from mouse stem cells reduces 5hmC levels and 
activity of enhancers [41]. It is interesting, in this context, 
that the bisulphite sequencing protocol used in the current 
study is unable to differentiate 5mC from 5hmC so that it is 
as likely that the increased levels of 5mC observed within 
GAL5.1 as a consequence of maternal HFD intake actually 
reflects an increase in 5hmC levels. The possible role of 
5hmC in upregulating enhancer activity, and our inability 
to differentiate 5mC and 5hmC using bisulphite conversion, 
may also explain the observations of increased 5mC/5hmC 
levels in hypothalamus and amygdala compared with the 
hippocampus that parallel the levels of Gal mRNA expres-
sion, which are significantly higher in hypothalamus and 
amygdala compared with hippocampus. Alternative meth-
ods of differentiating between genomic 5mC and 5hmC are 
now available which could help clarify the situation [42]. 
One fascinating possible contributory mechanism which 
might influence the changes in 5mC/5hmC levels observed 
in GAL5.1 due to HFD intake are the effects of HFD intake 
on gut microbiota [43]. Subsequent experiments will explore 
this possibility.
We designed a unique experiment to determine the effects 
of 5mC on the activity of the GAL5.1 enhancer and its 
response to EGR1 transcription factor binding and PKC ago-
nism that we have shown stimulate activity of the GAL5.1 
enhancer. To achieve this we cloned the GAL5.1 enhancer 
into a luciferase reporter vector (pCpGfree-lucia) that con-
tained no CpG dinucleotides. This allowed us to selectively 
methylate CpG dinucleotides within the GAL5.1 enhancer, 
using the SssI enzyme, without affecting the vector back-
bone. These studies showed that CpG methylation of the 
GAL5.1 enhancer has a significant repressive effect on its 
activity in SHSY-5Y cells and confirmed previous studies 
demonstrating the repressive effects of 5mC on regulatory 
activity. However, our studies could not explore the effects 
of 5hmC on enhancer activity, which has been associated 
with increased enhancer activity [38–41]. Thanks to the 
recent availability of recombinant TET-proteins, that are 
able to convert 5mC to 5hmC, it may be possible to com-
pare the effects of 5mC and 5hmC on GAL5.1 action in the 
near future [44].
Previous studies have shown that the binding affinity of 
the EGR1 transcription factor to DNA is not affected by 
5mC [45]. However, we observed that 5mC suppressed 
GAL5.1 activity even in the presence of EGR1 expression 
that we have previously shown upregulated activity of the 
enhancer. This suggests that the binding of another transcrip-
tion factor; who’s binding to DNA is affected by CpG 5mC, 
is critical to the normal functioning of GAL5.1. Identifying 
this transcription factor will be a major goal of subsequent 
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analyses. 5mC CpGs within GAL5.1 also have a significant 
impact on the response of GAL5.1 to activation of the PKC 
pathway. Thus, the ability of 5mC to repress PKC activation 
of GAL5.1, even in the presence of EGR1, represents further 
evidence for the need to identify a second 5mC sensitive 
transcription factor in the normal response of GAL5.1. Inter-
estingly, levels of activity of the fully methylated GAL5.1 
enhancer in the presence of both EGR1 transcription factor 
expression and PMA do not differ significantly from that of 
the unmethylated GAL5.1 enhancer in the absence of these 
stimuli suggesting that the effects of 5mC on GAL5.1 might 
be overcome by increased TF binding and stimulation of 
signal transduction pathways in vivo. In the context of the 
role of the EGR1 transcription factor in modulating levels 
of 5mC/5hmC at the GAL5.1 locus it is also interesting that 
recent studies have identified EGR1 as a major recruiter of 
TET proteins to specific loci [46] a consideration which we 
will also consider in the design of future studies.
In the wider context of the relationship of maternal 
high-fat diet to increased susceptibility to substance abuse 
and anxiety, the current study raises the possibility of the 
mechanistic contribution of the GAL5.1 enhancer in this 
process. We have previously shown that GAL5.1 governs 
ethanol intake and anxiety-related behaviour in mice that is 
mirrored by a significant association between alcohol abuse 
and increased anxiety in humans [24]. In the current study 
we show that high-fat diet causes a significant change in 
5mC/5hmC levels that are known to affect enhancer activity 
and that, in turn, GAL5.1 governs the decision to eat high-
fat diet but also affects anxiety and alcohol intake. Taken 
together, we propose that maternal high-fat diet induced 
changes in GAL5.1 5mC/5hmC levels may alter GAL5.1 
activity in subsequent generations in such a way as to affect 
the ability of GAL5.1 to affect anxiety and the decision to 
drink excess alcohol in subsequent generations.
Conclusions
Whilst much remains to be done to differentiate the effects 
of environmental influence on the distribution of 5mC and 
5hmC in GAL5.1, and how 5mC and 5hmC differentially 
affect GAL5.1 activity at a tissue specific level, the fact 
remains that we have identified a compelling epigenetic 
mechanism that may link the maternal intake of high-fat 
diet to the modulation of anxiety and alcohol intake in sub-
sequent generations. These unique studies also provide an 
important stepping stone to discover the influence of envi-
ronmentally modulated regulatory mechanisms in the devel-
opment of neuropsychiatric disorders.
Acknowledgements AMcE, AMcK and CM were funded by BBSRC 
project grant (BB/N017544/1) and Tenovus Scotland Grampian (award 
G19.08). We thank all of the staff at the Medical Research Facility for 
their help and excellent advice in the completion of these studies. We 
also thank Giuseppe D’agostino for guidence and help through the 
study.
Compliance with ethical standards 
Conflict of interest None of the authors declare any conflicts of inter-
est.
Open Access This article is licensed under a Creative Commons Attri-
bution 4.0 International License, which permits use, sharing, adapta-
tion, distribution and reproduction in any medium or format, as long 
as you give appropriate credit to the original author(s) and the source, 
provide a link to the Creative Commons licence, and indicate if changes 
were made. The images or other third party material in this article are 
included in the article’s Creative Commons licence, unless indicated 
otherwise in a credit line to the material. If material is not included in 
the article’s Creative Commons licence and your intended use is not 
permitted by statutory regulation or exceeds the permitted use, you will 
need to obtain permission directly from the copyright holder. To view a 
copy of this licence, visit http://creat iveco mmons .org/licen ses/by/4.0/.
References
 1. Liu D, Archer N, Duesing K, Hannan G, Keast R (2016) Mecha-
nism of fat taste perception: association with diet and obesity. 
Prog Lipid Res 63:41–49
 2. Erlanson-Albertsson C (2010) Fat-rich food palatability and 
appetite regulation. In: Montmayeur JP, Coutre J (eds) Fat 
detection taste texture, and post ingestive effects. Boca Raton, 
FL
 3. Sullivan EL, Riper KM, Lockard R, Valleau JC (2015) Maternal 
high-fat diet programming of the neuroendocrine system and 
behavior. Horm Behav 76:153–161
 4. Rivera HM, Christiansen KJ, Sullivan EL (2015) The role of 
maternal obesity in the risk of neuropsychiatric disorders. Front 
Neurosci 9:194
 5. Kang SS, Kurti A, Fair DA, Fryer JD (2014) Dietary inter-
vention rescues maternal obesity induced behavior deficits and 
neuroinflammation in offspring. J Neuroinflammation 11:156
 6. Peleg-Raibstein D, Luca E, Wolfrum C (2012) Maternal high-fat 
diet in mice programs emotional behavior in adulthood. Behav 
Brain Res 233:398–404
 7. Yan Z, Jiao F, Yan X, Ou H (2017) Maternal chronic folate 
supplementation ameliorates behavior disorders induced by pre-
natal high-fat diet through methylation alteration of BDNF and 
Grin2b in offspring hippocampus. Mol Nutr Food Res 61:9
 8. Johnson SA, Javurek AB, Painter MS, Murphy CR, Conard 
CM, Gant KL, Howald EC, Ellersieck MR, Wiedmeyer CE, 
Vieira-Potter VJ, Rosenfeld CS (2017) Effects of a maternal 
high-fat diet on offspring behavioral and metabolic parameters 
in a rodent model. J Dev Orig Health Dis 8:75–88
 9. Glendining KA, Fisher LC, Jasoni CL (2018) Maternal high fat 
diet alters offspring epigenetic regulators, amygdala glutamater-
gic profile and anxiety. Psychoneuroendocrinology 96:132–141
 10. Karatayev O, Lukatskaya O, Moon SH, Guo WR, Chen D, 
Algava D, Abedi S, Leibowitz SF (2015) Nicotine and ethanol 
co-use in Long-Evans rats: stimulatory effects of perinatal expo-
sure to a fat-rich diet. Alcohol 49:479–489
 11. Hokfelt T, Bartfai T, Bloom F (2003) Neuropeptides: opportuni-
ties for drug discovery. Lancet Neurol 2:463–472
 A. McEwan et al.
1 3
 12. Barson JR, Morganstern I, Leibowitz SF (2012) Neurobiology 
of consummatory behavior: mechanisms underlying overeating 
and drug use. ILAR J 53:35–58
 13. Barson JR, Morganstern I, Leibowitz SF (2011) Similarities in 
hypothalamic and mesocorticolimbic circuits regulating the over-
consumption of food and alcohol. Physiol Behav 104:128–137
 14. Adams AC, Clapham JC, Wynick D, Speakman JR (2008) Feed-
ing behaviour in galanin knockout mice supports a role of gala-
nin in fat intake and preference. J Neuroendocrinol 20:199–206
 15. Hokfelt T, Barde S, Xu ZD, Kuteeva E, Ruegg J, Le Maitre E, 
Risling M, Kehr J, Ihnatko R, Theodorsson E, Palkovits M, 
Deakin W, Bagdy G, Juhasz G, Prud’homme HJ, Mechawar 
N, Diaz-Heijtz R, Ogren SO (2018) Neuropeptide and small 
transmitter coexistence: fundamental studies and relevance to 
mental illness. Front Neural Circuits 12:106
 16. Kormos V, Gaszner B (2013) Role of neuropeptides in anxiety, 
stress, and depression: from animals to humans. Neuropeptides 
47:401–419
 17. Lin EJ (2012) Neuropeptides as therapeutic targets in anxiety 
disorders. Curr Pharm Des 18:5709–5727
 18. Madaan V, Wilson DR (2009) Neuropeptides: relevance in treat-
ment of depression and anxiety disorders. Drug News Perspect 
22:319–324
 19. Karatayev O, Baylan J, Leibowitz SF (2009) Increased intake of 
ethanol and dietary fat in galanin overexpressing mice. Alcohol 
43:571–580
 20. Karatayev O, Baylan J, Weed V, Chang S, Wynick D, Leibowitz 
SF (2010) Galanin knockout mice show disturbances in ethanol 
consumption and expression of hypothalamic peptides that stimu-
late ethanol intake. Alcohol Clin Exp Res 34:72–80
 21. Lewis MJ, Rada P, Johnson DF, Avena NM, Leibowitz SF, Hoe-
bel BG (2005) Galanin and alcohol dependence: neurobehavioral 
research. Neuropeptides 39:317–321
 22. Rada P, Avena NM, Leibowitz SF, Hoebel BG (2004) Ethanol 
intake is increased by injection of galanin in the paraventricular 
nucleus and reduced by a galanin antagonist. Alcohol 33:91–97
 23. Davidson S, Lear M, Shanley L, Hing B, Baizan-Edge A, Herwig 
A, Quinn JP, Breen G, McGuffin P, Starkey A, Barrett P, Mac-
Kenzie A (2011) Differential activity by polymorphic variants of 
a remote enhancer that supports galanin expression in the hypo-
thalamus and amygdala: implications for obesity, depression and 
alcoholism. Neuropsychopharmacology 36:2211–2221
 24. McEwan AR, Davidson C, Hay EA, Turnbull Y, Erickson JC, 
Marini P, Wilson D, McIntosh AM, Adams MJ, Murgatroyd 
C, Barrett P, Delibegovic M, Clarke TK, MacKenzie A (2020) 
CRISPR disruption and UK Biobank analysis of a highly con-
served polymorphic enhancer suggests a role in male anxiety and 
ethanol intake. Mole Psychiatry 1:9
 25. Murgatroyd C, Patchev AV, Wu Y, Micale V, Bockmuhl Y, Fis-
cher D, Holsboer F, Wotjak CT, Almeida OF, Spengler D (2009) 
Dynamic DNA methylation programs persistent adverse effects 
of early-life stress. Nat Neurosci 12:1559–1566
 26. Hay EA, Cowie P, McEwan AR, Ross R, Pertwee RG, MacKenzie 
A (2020) Disease-associated polymorphisms within the conserved 
ECR1 enhancer differentially regulate the tissue-specific activity 
of the cannabinoid-1 receptor gene promoter; implications for can-
nabinoid pharmacogenetics. Hum Mutat 41:291–298
 27. Liu C, Marioni RE, Hedman AK, Pfeiffer L, Tsai PC, Reynolds 
LM, Just AC, Duan Q, Boer CG, Tanaka T, Elks CE, Aslibekyan 
S, Brody JA, Kuhnel B, Herder C, Almli LM, Zhi D, Wang Y, 
Huan T, Yao C, Mendelson MM, Joehanes R, Liang L, Love 
SA, Guan W, Shah S, McRae AF, Kretschmer A, Prokisch H, 
Strauch K, Peters A, Visscher PM, Wray NR, Guo X, Wiggins 
KL, Smith AK, Binder EB, Ressler KJ, Irvin MR, Absher DM, 
Hernandez D, Ferrucci L, Bandinelli S, Lohman K, Ding J, Tre-
visi L, Gustafsson S, Sandling JH, Stolk L, Uitterlinden AG, Yet 
I, Castillo-Fernandez JE, Spector TD, Schwartz JD, Vokonas P, 
Lind L, Li Y, Fornage M, Arnett DK, Wareham NJ, Sotoodehnia 
N, Ong KK, van Meurs JBJ, Conneely KN, Baccarelli AA, Deary 
IJ, Bell JT, North KE, Liu Y, Waldenberger M, London SJ, Ingels-
son E, Levy D (2018) A DNA methylation biomarker of alcohol 
consumption. Mol Psychiatry 23:422–433
 28. Wynick D, Small CJ, Bacon A, Holmes FE, Norman M, Ormandy 
CJ, Kilic E, Kerr NC, Ghatei M, Talamantes F, Bloom SR, Pach-
nis V (1998) Galanin regulates prolactin release and lactotroph 
proliferation. Proc Natl Acad Sci U S A 95:12671–12676
 29. Niehrs C, Calkhoven CF (2020) Emerging role of C/EBPbeta and 
epigenetic DNA methylation in ageing. Trends Genet 36:71–80
 30. Angeloni A, Bogdanovic O (2019) Enhancer DNA methylation: 
implications for gene regulation. Essays Biochem 63:707–715
 31. Avrahami D, Kaestner KH (2019) The dynamic methylome of 
islets in health and disease. Mol Metab 27:S25–S32
 32. Keleher MR, Zaidi R, Hicks L, Shah S, Xing X, Li D, Wang T, 
Cheverud JM (2018) A high-fat diet alters genome-wide DNA 
methylation and gene expression in SM/J mice. BMC Genomics 
19:888
 33. Stadler MB, Murr R, Burger L, Ivanek R, Lienert F, Scholer A, 
Wirbelauer C, Oakeley EJ, Gaidatzis D, Tiwari VK, Schubeler D 
(2011) DNA-binding factors shape the mouse methylome at distal 
regulatory regions. Nature 480:490–495
 34. Jones PL, Veenstra GJ, Wade PA, Vermaak D, Kass SU, Lands-
berger N, Strouboulis J, Wolffe AP (1998) Methylated DNA and 
MeCP2 recruit histone deacetylase to repress transcription. Nat 
Genet 19:187–191
 35. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman 
RN, Bird A (1998) Transcriptional repression by the methyl-CpG-
binding protein MeCP2 involves a histone deacetylase complex. 
Nature 393:386–389
 36. Thurman RE, Rynes E, Humbert R, Vierstra J, Maurano MT, Hau-
gen E, Sheffield NC, Stergachis AB, Wang H, Vernot B, Garg K, 
John S, Sandstrom R, Bates D, Boatman L, Canfield TK, Diegel 
M, Dunn D, Ebersol AK, Frum T, Giste E, Johnson AK, Johnson 
EM, Kutyavin T, Lajoie B, Lee BK, Lee K, London D, Lotakis D, 
Neph S, Neri F, Nguyen ED, Qu H, Reynolds AP, Roach V, Safi 
A, Sanchez ME, Sanyal A, Shafer A, Simon JM, Song L, Vong 
S, Weaver M, Yan Y, Zhang Z, Zhang Z, Lenhard B, Tewari M, 
Dorschner MO, Hansen RS, Navas PA, Stamatoyannopoulos G, 
Iyer VR, Lieb JD, Sunyaev SR, Akey JM, Sabo PJ, Kaul R, Furey 
TS, Dekker J, Crawford GE, Stamatoyannopoulos JA (2012) The 
accessible chromatin landscape of the human genome. Nature 
489:75–82
 37. Yin Y, Morgunova E, Jolma A, Kaasinen E, Sahu B, Khund-Say-
eed S, Das PK, Kivioja T, Dave K, Zhong F, Nitta KR, Taipale M, 
Popov A, Ginno PA, Domcke S, Yan J, Schubeler D, Vinson C, 
Taipale J (2017) Impact of cytosine methylation on DNA binding 
specificities of human transcription factors. Science 7:356
 38. Zhu T, Brown AP, Ji H (2020) The emerging role of ten-eleven 
translocation 1 in epigenetic responses to environmental expo-
sures. Epigenet Insights 13:2516865720910155
 39. Spruijt CG, Gnerlich F, Smits AH, Pfaffeneder T, Jansen PW, 
Bauer C, Munzel M, Wagner M, Muller M, Khan F, Eberl HC, 
Mensinga A, Brinkman AB, Lephikov K, Muller U, Walter J, 
Boelens R, van Ingen H, Leonhardt H, Carell T, Vermeulen M 
(2013) Dynamic readers for 5-(hydroxy)methylcytosine and its 
oxidized derivatives. Cell 152:1146–1159
 40. Stroud H, Feng S, Morey Kinney S, Pradhan S, Jacobsen SE 
(2011) 5-Hydroxymethylcytosine is associated with enhancers 
and gene bodies in human embryonic stem cells. Genome Biol 
12:R54
 41. Hon GC, Rajagopal N, Shen Y, McCleary DF, Yue F, Dang 
MD, Ren B (2013) Epigenetic memory at embryonic enhancers 
The anxiety and ethanol intake controlling GAL5.1 enhancer is epigenetically modulated by,…
1 3
identified in DNA methylation maps from adult mouse tissues. 
Nat Genet 45:1198–1206
 42. Booth MJ, Branco MR, Ficz G, Oxley D, Krueger F, Reik W, 
Balasubramanian S (2012) Quantitative sequencing of 5-methyl-
cytosine and 5-hydroxymethylcytosine at single-base resolution. 
Science 336:934–937
 43. Yao H, Fan C, Lu Y, Fan X, Xia L, Li P, Wang R, Tang T, Wang 
Y, Qi K (2020) Alteration of gut microbiota affects expression of 
adiponectin and resistin through modifying DNA methylation in 
high-fat diet-induced obese mice. Genes Nutr 15:12
 44. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno 
Y, Agarwal S, Iyer LM, Liu DR, Aravind L, Rao A (2009) Con-
version of 5-methylcytosine to 5-hydroxymethylcytosine in mam-
malian DNA by MLL partner TET1. Science 324:930–935
 45. Hashimoto H, Olanrewaju YO, Zheng Y, Wilson GG, Zhang X, 
Cheng X (2014) Wilms tumor protein recognizes 5-carboxylcyto-
sine within a specific DNA sequence. Genes Dev 28:2304–2313
 46. Sun Z, Xu X, He J, Murray A, Sun MA, Wei X, Wang X, McCoig 
E, Xie E, Jiang X, Li L, Zhu J, Chen J, Morozov A, Pickrell AM, 
Theus MH, Xie H (2019) EGR1 recruits TET1 to shape the brain 
methylome during development and upon neuronal activity. Nat 
Commun 10:3892
Publisher’s Note Springer Nature remains neutral with regard to 
jurisdictional claims in published maps and institutional affiliations.
